<DOC>
	<DOCNO>NCT01935154</DOCNO>
	<brief_summary>Patients stage IV recurrent stage I-III NSCLC document disease control ( objective response stable disease ) within 3 week platinum base 1st line chemotherapy ; HLA-A*0201 positive patient TERT express tumor include . The objective trial survival rate 12 month .</brief_summary>
	<brief_title>Efficacy Study Vx001 Vaccine NSCLC Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Main 1 . Male female â‰¥18 year age ; 2 . Documented stage IV NSCLC define IASLC Lung Cancer Staging Project ( 7th edition ) recurrent stage IIII disease least 6 month resection end adjuvant chemotherapy standard locoregional treatment define American College Chest Physicians ; 3 . Patients treat 4 cycle platinum base 1st line chemotherapy define American College Chest Physicians ( i.e . radiotherapy allow except palliative radiotherapy bone metastasis ) ; 4 . Documented HLAA*0201 positivity , determine local laboratory ; 5 . TERTpositive NSCLC , assess central laboratory ; , availability adequate tissue biopsy primary tumor , lymph node distant metastasis prerequisite ; 6 . CR , PR , SD accord RECIST 1.1 criterion completion platinumbased firstline chemotherapy ; 7 . ECOG performance status 0 , 1 ; Main 1 . Mixed small cell NSCLC histologies ; 2 . Patients stage IV recurrent NSCLC previously treat therapy platinumbased firstline chemotherapy ; 3 . Prior treatment cancer vaccine ; 4 . Prior treatment immunotherapy ( e.g. , interferon , interleukin , TNF , biological response modifier , GMCSF etc ) within four week prior randomization ; 5 . Prior treatment hormone ( include corticosteroid ) within 2 week prior randomization ; 6 . Prior treatment investigational drug , within 4 week prior randomization ; 7 . Patients brain metastasis ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>Vaccine</keyword>
</DOC>